Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation an...
Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding
About this item
Full title
Author / Creator
Publisher
Poznan: Termedia Publishing House
Journal title
Language
English
Formats
Publication information
Publisher
Poznan: Termedia Publishing House
Subjects
More information
Scope and Contents
Contents
Aim To evaluate retrospectively the impact of ticagrelor or clopidogrel in patients taking dual antiplatelet aggregation therapy (DAPT, ASA + clopidogrel or ticagrelor) undergoing coronary artery bypass grafting (CABG) on postoperative bleeding complications and need for mediastinal surgical re-exploration, focusing on the interval of discontinuati...
Alternative Titles
Full title
Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_fbf3d77335f34cf5aa7ab1c3d5afceda
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fbf3d77335f34cf5aa7ab1c3d5afceda
Other Identifiers
ISSN
1731-5530
E-ISSN
1897-4252
DOI
10.5114/kitp.2019.91386
